Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephane Verguet, Ph.D.

Title
Institution
Department
Address
Profile Picture

Overview
overview
Stephane Verguet is Assistant Professor of Global Health at the Harvard T.H. Chan School of Public Health. Dr. Verguet's multidisciplinary research focuses on health decision science and priority setting, particularly the development of mathematical and computational decision-making models to better design health policies. His research interests include health economics, cost-effectiveness analysis, equity, and health systems performance. Most recently, he has been working on the estimation of non-health benefits, particularly the poverty alleviation benefits, of health policies and interventions.

Research areas and projects

Priority setting

Methods: Extended cost-effectiveness analysis (ECEA).

I have co-led the development of the methodology of "extended cost-effectiveness analysis" (ECEA), which attempts to incorporate the distributional, equity and poverty reduction benefits of policies into traditional economic evaluation methods. ECEA methods have now been widely used as the key economic methodology for the Disease Control Priorities, 3rd edition (www.dcp-3.org).

• Verguet S, Laxminarayan R, Jamison DT. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Economics 2015; 24(3):318-332.

http://onlinelibrary.wiley.com/doi/10.1002/hec.3019/full

• Verguet S, Olson Z, Babigumira J, Desalegn D, Johansson KA, Kruk ME, Levin CE, Nugent RA, Pecenka C, Shrime MG, Tessema Memirie S, Watkins DA, Jamison DT. Health gains and financial risk protection afforded from public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis. Lancet Global Health 2015; 3:e288-296.

http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70346-8/abstract

• Verguet S, Kim JJ, Jamison DT. Extended cost-effectiveness analysis for health policy assessment: a tutorial PharmacoEconomics 2016; 24(3):318-332.

http://link.springer.com/article/10.1007%2Fs40273-016-0414-z

Example of applications: equity and poverty alleviation benefits of vaccines.

To estimate the equity and poverty reduction benefits of vaccines in low- and middle-income countries, and to pursue a set of corresponding extended cost-effectiveness analysis economic evaluations.

• Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine 2013; 31(42):4902-4910.

http://www.sciencedirect.com/science/article/pii/S0264410X13009389

• Driessen JR, Olson ZD, Jamison DT, Verguet S. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: an extended cost-effectiveness analysis. Social Science and Medicine 2015; 139:115-122.

http://www.sciencedirect.com/science/article/pii/S0277953615003500
Disease Control Priorities - Ethiopia (DCP-E)

DCP-E intends to bring evidence and methods of priority setting and health economics closer to policy decision-making in Ethiopia. To achieve this purpose, three objectives are important:

1. To develop health economic evaluation and priority setting capacity in Ethiopia.
2. To provide input, through research and evidence, to the revision of the essential health care package for Ethiopia.
3. To establish a process to support health priority setting in Ethiopia, including assessing the cost-effectiveness of selected health sector interventions, packages, and delivery platforms.

• Memirie ST, Verguet S, Norheim OF, Levin C, Johansson KA. Inequalities in utilization of maternal and child health services in Ethiopia: the role of primary health care. BMC Health Services Research 2016.

https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-016-1296-7

• Tolla MT, Norheim OF, Memirie ST, Abdisa SG, Ababulgu A, Jerene D, Bertram M, Strand K, Verguet S, Johansson KA. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation 2016.

https://resource-allocation.biomedcentral.com/articles/10.1186/s12962-016-0059-y

• Verguet S, Memirie ST, Norheim OF. Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia. BMC Medicine 2016.

https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0697-0

Big data and health system modeling

I study health system performance and country performance on health through a quantitative lens that draws on a set of innovative approaches. In particular, we use mathematical and computational frameworks from physics and systems engineering to design dynamic models that replicate health system behaviors in real life, and, envision new potential relationships between the basic building blocks of health delivery in low- and middle-income countries. This includes the examination of trends in the evolution of health indicators over time, the study of the integration and the potential positive/negative synergies of certain delivery platforms with other health services, and the health systems more broadly.

• Verguet S, Jamison DT. Estimates of performance in the rate of decline of under-five mortality for 113 low- and middle-income countries, 1970-2010. Health Policy and Planning 2014; 29(2):151.

http://heapol.oxfordjournals.org/content/29/2/151.abstract

• Verguet S, Norheim OF, Olson ZD, Yamey G, Jamison DT. Performance in reducing child, maternal, HIV and tuberculosis mortality rates across 109 low- and middle-income countries from 1990-2013. Lancet Global Health 2014; 2:e698-709.

http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70316-X/abstract

• Verguet S, Jassat W, Bertram MY, Tollman S, Murray CJL, Jamison DT, Hofman KJ. Impact of supplementary immunization activities (SIAs) on health systems: findings from South Africa. Journal of Epidemiology and Community Health 2013; 67:947-952. http://jech.bmj.com/content/67/11/947.short

Mathematical modeling

I have designed decision-making models including a range of mathematical techniques (e.g. analytical functions, differential equations, optimization) in order to address a variety of problems in global public health, such as infectious disease transmission, resource allocation questions, and demographic modeling.

• Verguet S, Johri M, Morris S, Gauvreau C, Jha P, Jit M. Controling measles using supplemental immunization activities: a mathematical model to inform optimal policy. Vaccine 2015; 33:1291.

http://www.sciencedirect.com/science/article/pii/S0264410X14016077

• Verguet S, Lim SS, Murray CJL, Gakidou E, Salomon JA. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. Journal of Infectious Diseases 2013; 207(1):72.

http://jid.oxfordjournals.org/content/207/1/72.abstract

• Verguet S. Efficient and equitable HIV prevention: a case study of male circumcision in South Africa. Cost Effectiveness and Resource Allocation 2013; 11:1.

https://resource-allocation.biomedcentral.com/articles/10.1186/1478-7547-11-1
Tobacco control

On the question of how to expand tobacco control, favored tactics include increased excise taxes on tobacco products, and the expansion and enforcement of smoke-free zones. I have been working to evaluate the distributional consequences of these approaches (across socio-economic groups and geographical settings) in terms of health benefits, equity and poverty reduction benefits to households.

• Verguet S, Gauvreau C, Mishra S, MacLennan M, Murphy S, Brouwer E, Nugent RA, Zhao K, Jha P, Jamison DT. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Global Health 2015; 3:e206.

http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(15)70095-1/abstract

• Salti N, Brouwer ED, Verguet S. The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon. Social Science and Medicine 2016; 170:161-169.

http://www.sciencedirect.com/science/article/pii/S0277953616305883
webpage

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R03HD082443 (VERGUET, STEPHANE) Jun 28, 2015 - May 31, 2018
    NIH
    Impact of supplemental immunization activity campaigns on health systems
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Verguet S, Bolongaita S, Morgan A, Perumal N, Sudfeld CR, Yousafzai AK, Fink G. Priority setting in early childhood development: an analytical framework for economic evaluation of interventions. BMJ Glob Health. 2022 06; 7(6). PMID: 35725241; PMCID: PMC9214350.
    Citations:    Fields:    Translation:Humans
  2. Verguet S, Memirie ST, Tolla MT, Jamison DT. Global health priority setting: beyond cost-effectiveness. Extended cost-effectiveness analysis. 2021.
  3. Hendrix N, Veenstra D, Cheng M, Anderson NC, Verguet S. Assessing the Economic Value of Clinical Artificial Intelligence: Challenges and Opportunities. Value in Health. 2021.
  4. Lofgren KT, Watkins DA, Memirie ST, Salomon JA, Verguet S. Balancing health and financial protection in health benefit package design. Health Econ. 2021 12; 30(12):3236-3247. PMID: 34626032; PMCID: PMC9293346.
    Citations:    Fields:    Translation:Humans
  5. Verguet S, Norheim OF. Estimating and Comparing Health and Financial Risk Protection Outcomes in Economic Evaluations. Value Health. 2022 02; 25(2):238-246. PMID: 35094797.
    Citations: 1     Fields:    Translation:Humans
  6. Verguet S, Norheim OF. Estimating and Comparing Health and Financial Risk Protection Outcomes in Economic Evaluations. Value in Health. 2021.
  7. Jbaily A, Haakenstad A, Kiros M, Riumallo-Herl C, Verguet S. Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures. Eur J Health Econ. 2022 Jul; 23(5):903-912. PMID: 34355280; PMCID: PMC9170678.
    Citations:    Fields:    Translation:Humans
  8. Arsenault C, Yakob B, Kassa M, Dinsa G, Verguet S. Using health management information system data: case study and verification of institutional deliveries in Ethiopia. BMJ Glob Health. 2021 08; 6(8). PMID: 34426404; PMCID: PMC8383857.
    Citations: 2     Fields:    Translation:Humans
  9. Khadka A, Verguet S. The economic value of changing mortality risk in low- and middle-income countries: a systematic breakdown by cause of death. BMC Med. 2021 07 16; 19(1):156. PMID: 34266420.
    Citations:    Fields:    Translation:Humans
  10. Jamison JC, Bundy D, Jamison DT, Spitz J, Verguet S. Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries. Health Serv Res. 2021 10; 56(5):874-884. PMID: 34182593; PMCID: PMC8441808.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  11. Allison Portnoy, Steven Sweet, Dawit Desalegn, Solomon Tessema Memirie, Jane J Kim, Stéphane Verguet. Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study. Health Policy and Planning. 2021.
  12. Menkir TF, Jbaily A, Verguet S. Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission. Vaccine. 2021 05 18; 39(21):2894-2900. PMID: 33863575.
    Citations:    Fields:    Translation:HumansPHPublic Health
  13. Verguet S, Hailu A, Eregata GT, Memirie ST, Johansson KA, Norheim OF. Toward universal health coverage in the post-COVID-19 era. Nat Med. 2021 03; 27(3):380-387. PMID: 33723458.
    Citations: 9     Fields:    Translation:HumansCells
  14. Solomon T Memirie, Mulat Nigus, Stéphane Verguet. Cost-effectiveness and equitable access to vaccines in Ethiopia: an overview and evidence synthesis of the published literature. Journal of Global Health Reports. 2021; 5.
  15. Li X, Mukandavire C, Cucunubá ZM, Echeverria Londono S, Abbas K, Clapham HE, Jit M, Johnson HL, Papadopoulos T, Vynnycky E, Brisson M, Carter ED, Clark A, de Villiers MJ, Eilertson K, Ferrari MJ, Gamkrelidze I, Gaythorpe KAM, Grassly NC, Hallett TB, Hinsley W, Jackson ML, Jean K, Karachaliou A, Klepac P, Lessler J, Li X, Moore SM, Nayagam S, Nguyen DM, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Sy S, Tam Y, Tanvir H, Tran QM, Trotter CL, Truelove S, van Zandvoort K, Verguet S, Walker N, Winter A, Woodruff K, Ferguson NM, Garske T. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet. 2021 01 30; 397(10272):398-408. PMID: 33516338; PMCID: PMC7846814.
    Citations: 33     Fields:    Translation:HumansPHPublic Health
  16. Lamu AN, Jbaily A, Verguet S, Robberstad B, Norheim OF. Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo. BMC Public Health. 2020 Dec 07; 20(1):1869. PMID: 33287754.
    Citations: 3     Fields:    Translation:Humans
  17. Verguet S, Limasalle P, Chakrabarti A, Husain A, Burbano C, Drake L, Bundy DAP. The Broader Economic Value of School Feeding Programs in Low- and Middle-Income Countries: Estimating the Multi-Sectoral Returns to Public Health, Human Capital, Social Protection, and the Local Economy. Front Public Health. 2020; 8:587046. PMID: 33344398; PMCID: PMC7744483.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  18. Blanchet K, Alwan A, Antoine C, Cros MJ, Feroz F, Amsalu Guracha T, Haaland O, Hailu A, Hangoma P, Jamison D, Memirie ST, Miljeteig I, Jan Naeem A, Nam SL, Norheim OF, Verguet S, Watkins D, Johansson KA. Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the COVID-19 pandemic. BMJ Glob Health. 2020 10; 5(10). PMID: 33028701; PMCID: PMC7542611.
    Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
  19. Poole DN, Hedt-Gauthier B, Bärnighausen T, Verguet S, Castro MC. Spatial-temporal trends in forced migrant mortality, 2014-2018. BMJ Glob Health. 2020 10; 5(10). PMID: 33037060; PMCID: PMC7549474.
    Citations:    Fields:    Translation:Humans
  20. Bukhman G, Mocumbi AO, Atun R, Becker AE, Bhutta Z, Binagwaho A, Clinton C, Coates MM, Dain K, Ezzati M, Gottlieb G, Gupta I, Gupta N, Hyder AA, Jain Y, Kruk ME, Makani J, Marx A, Miranda JJ, Norheim OF, Nugent R, Roy N, Stefan C, Wallis L, Mayosi B. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. Lancet. 2020 10 03; 396(10256):991-1044. PMID: 32941823; PMCID: PMC7489932.
    Citations: 42     Fields:    Translation:Humans
  21. Alexander Kintu, David Sando, David Guwatudde, Silver Bahendeka, Peter C Kawungezi, Gerald Mutungi, Winnie Muyindike, Nicolas Menzies, Samson Okello, Goodarz Danaei, Stéphane Verguet. Quantifying the burden of cardiovascular diseases among people living with HIV in sub-Saharan Africa: findings from a modeling study for Uganda. Journal of Global Health Reports. 2020; 4.
  22. Li Z, Fawzi WW, Cohen JL, Verguet S. Equity and Distributional Impact on Stunting of a Nutritional Package Targeting Children Aged 6-36 Months in China: Findings from a Modeling Study. Nutrients. 2020 Aug 30; 12(9). PMID: 32872615.
    Citations:    Fields:    Translation:Humans
  23. Abdulrahman Jbaily, Isabelle Feldhaus, Benjamin Bigelow, Leila Kamareddine, Mieraf Taddesse Tolla, Marion Bouvier, Mizan Kiros, Stéphane Verguet . Toward health system strengthening in low- and middle-income countries: insights from mathematical modeling of drug supply chains. BMC Health Services Research. 2020; 20(1):776(12 pages).
  24. Mizan Kiros, Ermias Dessie, Abdulrahman Jbaily, Mieraf Taddesse Tolla, Kjell Arne Johansson, Ole F Norheim, Solomon Tessema Memirie, Stéphane Verguet. The burden of household out-of-pocket health expenditures in Ethiopia: estimates from a nationally representative survey (2015–16). Health Policy and Planning. 2020; 35(8):1003–1010.
  25. Julian C. Jamison, Donald Bundy, Dean T. Jamison, Jacob Spitz, Stéphane Verguet. Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries. Health Services Research. 2020.
  26. Verguet S, Kearns PKA, Rees VW. Questioning the regressivity of tobacco taxes: a distributional accounting impact model of increased tobacco taxation. Tob Control. 2021 05; 30(3):245-257. PMID: 32576701.
    Citations: 4     Fields:    Translation:HumansAnimals
  27. Portnoy A, Jit M, Helleringer S, Verguet S. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries. Value Health. 2020 07; 23(7):891-897. PMID: 32762991.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  28. Sando D, Kintu A, Okello S, Kawungezi PC, Guwatudde D, Mutungi G, Muyindike W, Menzies NA, Danaei G, Verguet S. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020 06; 23 Suppl 1:e25507. PMID: 32562364; PMCID: PMC7305460.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  29. Kintu A, Sando D, Okello S, Mutungi G, Guwatudde D, Menzies NA, Danaei G, Verguet S. Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa. J Int AIDS Soc. 2020 06; 23 Suppl 1:e25508. PMID: 32562370; PMCID: PMC7305410.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  30. Daniels KM, Riesel JN, Verguet S, Meara JG, Shrime MG. The Scale-Up of the Global Surgical Workforce: Can Estimates be Achieved by 2030? World J Surg. 2020 04; 44(4):1053-1061. PMID: 31858180.
    Citations: 2     Fields:    Translation:Humans
  31. De Neve JW, Harttgen K, Verguet S. Nationally and regionally representative analysis of 1.65 million children aged under 5 years using a child-based human development index: A multi-country cross-sectional study. PLoS Med. 2020 03; 17(3):e1003054. PMID: 32176692; PMCID: PMC7075547.
    Citations: 1     Fields:    Translation:Humans
  32. Assebe LF, Kwete XJ, Wang D, Liu L, Norheim OF, Jbaily A, Verguet S, Johansson KA, Tolla MT. Health gains and financial risk protection afforded by public financing of selected malaria interventions in Ethiopia: an extended cost-effectiveness analysis. Malar J. 2020 Jan 23; 19(1):41. PMID: 31973694.
    Citations: 3     Fields:    Translation:Humans
  33. Ying R, Fekadu L, Schackman BR, Verguet S. Spatial distribution and characteristics of HIV clusters in Ethiopia. Trop Med Int Health. 2020 03; 25(3):301-307. PMID: 31808592.
    Citations: 2     Fields:    Translation:Humans
  34. Benjamin Bigelow, Stephane Verguet . Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves. BMJ Open. 2020.
  35. Johansson KA, Tolla MT, Memirie ST, Miljeteig I, Habtemariam MK, Woldemariam AT, Verguet S, Norheim OF. Country contextualisation of cost-effectiveness studies: lessons from Ethiopia. BMJ Glob Health. 2019; 4(6):e001320. PMID: 31908853; PMCID: PMC6936444.
    Citations:    Fields:    
  36. Khadka A, Perales NA, Wei DJ, Gage AD, Haber N, Verguet S, Patenaude B, Fink G. Correction to: Malaria control across borders: quasi-experimental evidence from the Trans-Kunene malaria initiative (TKMI). Malar J. 2019 Nov 14; 18(1):365. PMID: 31727064; PMCID: PMC6854627.
    Citations:    Fields:    
  37. de Lemos LLP, Carvalho de Souza M, Pena Moreira D, Ribeiro Fernandes Almeida PH, Godman B, Verguet S, Guerra AA, Leal Cherchiglia M. Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis. PLoS One. 2019; 14(10):e0224012. PMID: 31618268; PMCID: PMC6799865.
    Citations: 9     Fields:    Translation:Humans
  38. Saxena A, Stacey N, Puech PDR, Mudara C, Hofman K, Verguet S. The distributional impact of taxing sugar-sweetened beverages: findings from an extended cost-effectiveness analysis in South Africa. BMJ Glob Health. 2019; 4(4):e001317. PMID: 31543983; PMCID: PMC6730580.
    Citations: 10     Fields:    
  39. Bigelow B, Desalegn DN, Salomon JA, Verguet S. Modelling hospital operations: insight from using data from paper registries in the obstetrics ward at a hospital in Addis Ababa, Ethiopia. BMJ Glob Health. 2019; 4(3):e001281. PMID: 31179031; PMCID: PMC6528765.
    Citations:    Fields:    
  40. Memirie ST, Tolla MT, Desalegn D, Hailemariam M, Norheim OF, Verguet S, Johansson KA. A cost-effectiveness analysis of maternal and neonatal health interventions in Ethiopia. Health Policy Plan. 2019 May 01; 34(4):289-297. PMID: 31106346; PMCID: PMC6661540.
    Citations: 11     Fields:    Translation:Humans
  41. Verguet S, Feldhaus I, Jiang Kwete X, Aqil A, Atun R, Bishai D, Cecchini M, Guerra Junior AA, Habtemariam MK, Jbaily A, Karanfil O, Kruk ME, Haneuse S, Norheim OF, Smith PC, Tolla MT, Zewdu S, Bump J. Health system modelling research: towards a whole-health-system perspective for identifying good value for money investments in health system strengthening. BMJ Glob Health. 2019; 4(2):e001311. PMID: 31139448; PMCID: PMC6509611.
    Citations: 8     Fields:    
  42. Wingfield T, Verguet S. Active case finding in tuberculosis-affected households: time to scale up. Lancet Glob Health. 2019 03; 7(3):e296-e298. PMID: 30784625.
    Citations: 6     Fields:    Translation:Humans
  43. Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob Health. 2019 04; 7(4):e472-e481. PMID: 30797735.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  44. Haakenstad A, Coates M, Marx A, Bukhman G, Verguet S. Disaggregating catastrophic health expenditure by disease area: cross-country estimates based on the World Health Surveys. BMC Med. 2019 02 13; 17(1):36. PMID: 30755209; PMCID: PMC6372998.
    Citations: 6     Fields:    Translation:Humans
  45. Jamison DT, Jamison JC, Norheim OF, Verguet S. Global health priority-setting: beyond cost-effectiveness. Inequality in survival. 2019.
  46. Ottersen T, Millum J, Ruger JP, Verguet S Johansson KA, Emanuel E, Jamison DT, Norheim OF. Global health priority-setting: beyond cost effectiveness. The future of priority setting in global health. 2019.
  47. Benjamin Bigelow, Dawit N Desalegn, Joshua A Salomon, Stéphane Verguet . Modelling hospital operations: insight from using data from paper registries in the obstetrics ward at a hospital in Addis Ababa, Ethiopia. BMJ Global Health. 2019.
  48. De Neve JW, Andriantavison RL, Croke K, Krisam J, Rajoela VH, Rakotoarivony RA, Rambeloson V, Schultz L, Qamruddin J, Verguet S. Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study. PLoS Negl Trop Dis. 2018 12; 12(12):e0007002. PMID: 30589847; PMCID: PMC6307713.
    Citations: 7     Fields:    Translation:Humans
  49. Hauck K, Morton A, Chalkidou K, Chi YL, Culyer A, Levin C, Meacock R, Over M, Thomas R, Vassall A, Verguet S, Smith PC. How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations. Soc Sci Med. 2019 01; 220:141-149. PMID: 30428401.
    Citations: 12     Fields:    Translation:Humans
  50. Memirie ST, Habtemariam MK, Asefa M, Deressa BT, Abayneh G, Tsegaye B, Abraha MW, Ababi G, Jemal A, Rebbeck TR, Verguet S. Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. J Glob Oncol. 2018 09; 4:1-11. PMID: 30241262.
    Citations: 52     Fields:    Translation:Humans
  51. James EK, Saxena A, Franco Restrepo C, Llorente B, Vecino-Ortiz AI, Villar Uribe M, Iunes RF, Verguet S. Distributional health and financial benefits of increased tobacco taxes in Colombia: results from a modelling study. Tob Control. 2019 07; 28(4):374-380. PMID: 30093415.
    Citations: 7     Fields:    Translation:Humans
  52. Chang AY, Riumallo-Herl C, Salomon JA, Resch SC, Brenzel L, Verguet S. Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries. BMC Med. 2018 07 04; 16(1):102. PMID: 29970074.
    Citations: 11     Fields:    Translation:Humans
  53. Khadka A, Perales NA, Wei DJ, Gage AD, Haber N, Verguet S, Patenaude B, Fink G. Malaria control across borders: quasi-experimental evidence from the Trans-Kunene malaria initiative (TKMI). Malar J. 2018 Jun 04; 17(1):224. PMID: 29866113; PMCID: PMC5987525.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  54. Skaftun EK, Verguet S, Norheim OF, Johansson KA. Geographic health inequalities in Norway: a Gini analysis of cross-county differences in mortality from 1980 to 2014. Int J Equity Health. 2018 05 24; 17(1):64. PMID: 29793490.
    Citations: 10     Fields:    Translation:Humans
  55. Postolovska I, Helleringer S, Kruk ME, Verguet S. Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries. BMJ Glob Health. 2018; 3(3):e000466. PMID: 29755760; PMCID: PMC5942424.
    Citations: 4     Fields:    
  56. Chang AY, Verguet S. Medical Impoverishment And Vaccines. Health Aff (Millwood). 2018 05; 37(5):828. PMID: 29733713.
    Citations:    Fields:    
  57. Riumallo-Herl C, Chang AY, Clark S, Constenla D, Clark A, Brenzel L, Verguet S. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study. BMJ Glob Health. 2018; 3(2):e000613. PMID: 29662691; PMCID: PMC5898318.
    Citations: 9     Fields:    
  58. Lin RT, Lin CK, Christiani DC, Kawachi I, Cheng Y, Verguet S, Jong S. Author Correction: The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparison. Sci Rep. 2018 Mar 12; 8(1):4654. PMID: 29531270.
    Citations: 1     Fields:    
  59. Loganathan T, Ng CW, Lee WS, Hutubessy RCW, Verguet S, Jit M. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia. Health Policy Plan. 2018 Mar 01; 33(2):204-214. PMID: 29228339.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  60. Chang AY, Riumallo-Herl C, Perales NA, Clark S, Clark A, Constenla D, Garske T, Jackson ML, Jean K, Jit M, Jones EO, Li X, Suraratdecha C, Bullock O, Johnson H, Brenzel L, Verguet S. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. Health Aff (Millwood). 2018 02; 37(2):316-324. PMID: 29401021.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  61. Erin Kinsella James, Akshar Saxena, Camila Franco Restrepo, Blanca Llorente, Andres I Vecino-Ortiz, Manuela Villar Uribe, Roberto F Iunes, Stéphane Verguet. Distributional health and financial benefits of increased tobacco taxes in Colombia: results from a modelling study. Tobacco Control. 2018.
  62. Verguet S, Tarr G, Gauvreau CL, Mishra S, Jha P, Liu L, Xiao Y, Qiu Y, Zhao K. Distributional benefits of tobacco tax and smoke-free workplaces in China: A modeling study. J Glob Health. 2017 Dec; 7(2):020701. PMID: 29188029; PMCID: PMC5681709.
    Citations: 7     Fields:    Translation:Humans
  63. Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, Blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, de Silva N, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia PJ, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul FM, Kobusingye O, Krakauer EL, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham A, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker DG, Walker N, Wu Y, Zhao K. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition. Lancet. 2018 03 17; 391(10125):1108-1120. PMID: 29179954; PMCID: PMC5996988.
    Citations: 46     Fields:    Translation:Humans
  64. Portnoy A, Jit M, Helleringer S, Verguet S. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Vaccine. 2018 01 02; 36(1):170-178. PMID: 29174680.
    Citations: 19     Fields:    Translation:HumansPHPublic Health
  65. Welch VA, Norheim OF, Jull J, Cookson R, Sommerfelt H, Tugwell P. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ. 2017 11 23; 359:j5085. PMID: 29170161.
    Citations: 32     Fields:    Translation:Humans
  66. Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya J-C, Nugent R, as part of the DCP3 Cardiovascular, respiratory, and related disorders Author Group. Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition. Lancet. 2017; 391(10121):687-699.
  67. Bundy DAP, de Silva N, Horton S, Patton GC, Schultz L, Jamison DT. Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition. Lancet. 2018 02 17; 391(10121):687-699. PMID: 29153316.
    Citations: 49     Fields:    Translation:Humans
  68. Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya JC, Nugent R. Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2018 03 24; 391(10126):1224-1236. PMID: 29108723; PMCID: PMC5996970.
    Citations: 41     Fields:    Translation:Humans
  69. Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health. 2017 11; 5(11):e1123-e1132. PMID: 29025634; PMCID: PMC5640802.
    Citations: 16     Fields:    Translation:Humans
  70. Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, Arreola-Ornelas H, Gómez-Dantés O, Rodriguez NM, Alleyne GAO, Connor SR, Hunter DJ, Lohman D, Radbruch L, Del Rocío Sáenz Madrigal M, Atun R, Foley KM, Frenk J, Jamison DT, Rajagopal MR. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018 04 07; 391(10128):1391-1454. PMID: 29032993.
    Citations: 217     Fields:    Translation:Humans
  71. Verguet S, Woldemariam AT, Durrett WN, Norheim OF, Kruk ME. Is the sustainable development goal target for financial risk protection in health realistic? BMJ Glob Health. 2017; 2(3):e000216. PMID: 29071127.
    Citations: 3     Fields:    
  72. Chang AY, Ogbuoji O, Atun R, Verguet S. Dynamic modeling approaches to characterize the functioning of health systems: A systematic review of the literature. Soc Sci Med. 2017 12; 194:160-167. PMID: 29100141.
    Citations: 12     Fields:    Translation:Humans
  73. Verguet S, Jones EO, Johri M, Morris SK, Suraweera W, Gauvreau CL, Jha P, Jit M. Characterizing measles transmission in India: a dynamic modeling study using verbal autopsy data. BMC Med. 2017 08 10; 15(1):151. PMID: 28793891.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  74. Tolla MT, Norheim OF, Verguet S, Bekele A, Amenu K, Abdisa SG, Johansson KA. Out-of-pocket expenditures for prevention and treatment of cardiovascular disease in general and specialised cardiac hospitals in Addis Ababa, Ethiopia: a cross-sectional cohort study. BMJ Glob Health. 2017; 2(2):e000280. PMID: 29242752; PMCID: PMC5584490.
    Citations: 26     Fields:    
  75. Sánchez-González L, Rodriguez-Lainz A, O'Halloran A, Rowhani-Rahbar A, Liang JL, Lu PJ, Houck PM, Verguet S, Williams WW. Factors Related to Pertussis and Tetanus Vaccination Status Among Foreign-Born Adults Living in the United States. J Community Health. 2017 Jun; 42(3):573-582. PMID: 27837358; PMCID: PMC5726518.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  76. Shrime MG, Alkire BC, Grimes C, Chao TE, Poenaru D, Verguet S. Cost-Effectiveness in Global Surgery: Pearls, Pitfalls, and a Checklist. World J Surg. 2017 06; 41(6):1401-1413. PMID: 28105528.
    Citations: 17     Fields:    Translation:Humans
  77. Iryna Postolovska, Rouselle F. Lavado, Gillian Tarr, Stephane Verguet. Estimating the distributional impact of increasing taxes on tobacco products in Armenia : results from an extended cost-effectiveness analysis. Health Systems & Reform. 2017; 4(1):30-41.
  78. Lin RT, Lin CK, Christiani DC, Kawachi I, Cheng Y, Verguet S, Jong S. The impact of the introduction of new recognition criteria for overwork-related cardiovascular and cerebrovascular diseases: a cross-country comparison. Sci Rep. 2017 03 13; 7(1):167. PMID: 28279019.
    Citations: 10     Fields:    
  79. Cookson R, Mirelman AJ, Griffin S, Asaria M, Dawkins B, Norheim OF, Verguet S, J Culyer A. Using Cost-Effectiveness Analysis to Address Health Equity Concerns. Value Health. 2017 02; 20(2):206-212. PMID: 28237196.
    Citations: 63     Fields:    Translation:Humans
  80. Memirie ST, Metaferia ZS, Norheim OF, Levin CE, Verguet S, Johansson KA. Household expenditures on pneumonia and diarrhoea treatment in Ethiopia: a facility-based study. BMJ Glob Health. 2017; 2(1):e000166. PMID: 28589003.
    Citations: 21     Fields:    
  81. Verguet S, Jamison DT. Disease Control Priorities. Health policy analysis: applications of extended cost effectiveness analysis (ECEA) methodology in DCP3. 2017; 9.
  82. Watkins DA, Nugent RA, Verguet S. Disease Control Priorities. Extended cost-effectiveness analysis (ECEA) for cardiovascular disease interventions. 2017; 5.
  83. Ogbuoji O, Olson ZD, Yamey G, Norheim OF, Verguet S, Jamison DT. Disease Control Priorities. Annual rates of decline in child, maternal, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2015. 2017; 9.
  84. Krakauer E, Ali Z, Arreola H, Bhadelia A, Connor S, de Lima L, Gelband H, Jamison DT, Thanh Khanh Q, Kwete X, Mpanumusingo E, Rajagopal MR, Tapela N, Verguet S, Knaul FM. Disease Control Priorities. Palliative care in response to the Global Burden of Remediable Suffering. 2017; 9.
  85. Watkins DA, Jamison DT, Mills A, Atun R, Danforth K, Glassman A, Horton S, Jha P, Kruk M, Norheim OF, Qi J, Soucat A, Verguet S, Wilson D, Alwan A. Disease Control Priorities. Universal health coverage and essential packages of care. 2017; 9.
  86. Verguet S, Nandi A, Filippi V, Bundy DP. Disease Control Priorities. Maternal deaths and impoverishment averted by postponing age at parity through education: an extended cost effectiveness analysis. 2017; 8.
  87. Olson Z, Staples JA, Mock C, Nguyen NP, Bachani AM, Nugent R, Verguet S. Injury prevention and environmental health. Helmet regulation in Vietnam: impact on health, equity, and medical impoverishment. 2017; 7.
  88. Mock C, Smith KR, Kobusingye O, Nugent R, Abdalla S, Ahuja R, Apramian S, Bachani A, Bellis MA, Butchart A, Cantley L, Chase C, Cullen M, Dabestani N, Ebi K, Fang X, Gururaj G, Guttikunda S, Hess J, Hoe CH, Hutton G, Hyder A, Ivers R, Jamison D, Jawahar P, Keay L, Levin C, Liao J, Mackie D, Malik K, Meddings D, Nguyen NP, Norton R, Olson Z, Partridge I, Peden M, Pillarisetti A, Rahman F, Rosenberg M, Staples JA, Verguet S, Ward C, Watkins D. Disease Control Priorities. Injury prevention and environmental health: key messages from the volume. 2017; 7.
  89. Verguet S, Jamison DT. What's in, what's out? Designing benefits for universal health coverage. Selecting health benefits packages in low- and middle income countries using the extended cost-effectiveness analysis (ECEA) methodology. 2017.
  90. Verguet S, Memirie ST, Norheim OF. Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia. BMC Med. 2016 10 21; 14(1):164. PMID: 27769296; PMCID: PMC5075208.
    Citations: 18     Fields:    Translation:Humans
  91. Salti N, Brouwer E, Verguet S. The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon. Soc Sci Med. 2016 12; 170:161-169. PMID: 27792922.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  92. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016 11; 4(11):e816-e826. PMID: 27720689; PMCID: PMC5527122.
    Citations: 44     Fields:    Translation:Humans
  93. Munshi V, Yamey G, Verguet S. Trends In State-Level Child Mortality, Maternal Mortality, And Fertility Rates In India. Health Aff (Millwood). 2016 10 01; 35(10):1759-1763. PMID: 27702946.
    Citations: 4     Fields:    Translation:Humans
  94. Verguet S, Nandi A, Filippi V, Bundy DA. Maternal-related deaths and impoverishment among adolescent girls in India and Niger: findings from a modelling study. BMJ Open. 2016 Sep 26; 6(9):e011586. PMID: 27670517.
    Citations: 3     Fields:    
  95. Kruk ME, Leslie HH, Verguet S, Mbaruku GM, Adanu RMK, Langer A. Quality of basic maternal care functions in health facilities of five African countries: an analysis of national health system surveys. Lancet Glob Health. 2016 11; 4(11):e845-e855. PMID: 27670090.
    Citations: 119     Fields:    Translation:Humans
  96. Verguet S, Kim JJ, Jamison DT. Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. Pharmacoeconomics. 2016 09; 34(9):913-23. PMID: 27374172; PMCID: PMC4980400.
    Citations: 49     Fields:    Translation:HumansPHPublic Health
  97. Loganathan T, Jit M, Hutubessy R, Ng CW, Lee WS, Verguet S. Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system. Trop Med Int Health. 2016 Nov; 21(11):1458-1467. PMID: 27503549.
    Citations:    Fields:    Translation:Humans
  98. Tolla MT, Norheim OF, Memirie ST, Abdisa SG, Ababulgu A, Jerene D, Bertram M, Strand K, Verguet S, Johansson KA. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis. Cost Eff Resour Alloc. 2016; 14:10. PMID: 27524939; PMCID: PMC4983058.
    Citations: 18     
  99. Tolla MT, Strand K, Memirie ST, Norheim OF, Senkoro K, Guteta S, Ababulgu A, Jerene D, Bertram M, Verguet S, Johansson KA. Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation. 2016; 14(10).
  100. Johri M, Verguet S, Morris SK, Sharma JK, Ram U, Gauvreau C, Jones E, Jha P, Jit M. Adding interventions to mass measles vaccinations in India. Bull World Health Organ. 2016 Oct 01; 94(10):718-727. PMID: 27843161; PMCID: PMC5043198.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  101. Verguet S. Defining Pathways and Trade-offs Toward Universal Health CoverageComment on "Ethical Perspective: Five Unacceptable Trade-offs on the Path to Universal Health Coverage". Int J Health Policy Manag. 2016 07 01; 5(7):445-447. PMID: 27694674; PMCID: PMC4930352.
    Citations: 1     Fields:    Translation:Humans
  102. Vikram Patel, Dan Chisholm, Rachana Parikh, Fiona J Charlson, Louisa Degenhardt, Tarun Dua,et al. As part of the DCP3 MNS Author Group. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016; 387(10028):P1672-1685.
  103. Verguet S, Pecenka C, Johansson KA, Memirie ST, Friberg IK, Driessen JR, Jamison DT. Health Gains and Financial Risk Protection Afforded by Treatment and Prevention of Diarrhea and Pneumonia in Ethiopia: An Extended Cost-Effectiveness Analysis. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). 2016. View Publication.
  104. Memirie ST, Verguet S, Norheim OF, Levin C, Johansson KA. Inequalities in utilization of maternal and child health services in Ethiopia: the role of primary health care. BMC Health Serv Res. 2016 Feb 12; 16:51. PMID: 26867540.
    Citations: 25     Fields:    Translation:Humans
  105. Olson Z, Staples JA, Mock C, Nguyen NP, Bachani AM, Nugent R, Verguet S. Helmet regulation in Vietnam: impact on health, equity and medical impoverishment. Inj Prev. 2016 08; 22(4):233-8. PMID: 26728008; PMCID: PMC4975813.
    Citations: 5     Fields:    Translation:Humans
  106. Verguet S, Gauvreau C, Mishra S, MacLennan M, Murphy S, Brouwer E, Nugent RA, Zhao K, Jha P, Jamison DT. Economics of tobacco control in China: from policy research to practice. The consequences of tobacco taxation on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. 2016.
  107. Chisholm D, Johansson KA, Raykar N, Megiddo I, Nigam A, Bjerkreim Strand K, Colson C, Fekadu A, Verguet S. Disease Control Priorities. Universal health coverage for mental, neurological, and substance use disorders: an extended cost-effectiveness analysis. 2016; 4.
  108. Verguet S, Pecenka C, Johansson KA, Memirie ST, Friberg IK, Driessen JR, Jamison DT. Disease Control Priorities. Health gains and financial risk protection afforded from prevention and treatment of diarrhea and pneumonia in Ethiopia. 2016; 2.
  109. Shrime MG, Verguet S, Johansson KA, Desalegn D, Jamison DT, Kruk ME. Task-sharing or public finance for the expansion of surgical access in rural Ethiopia: an extended cost-effectiveness analysis. Health Policy Plan. 2016 Jul; 31(6):706-16. PMID: 26719347.
    Citations: 10     Fields:    Translation:Humans
  110. Johansson KA, Memirie ST, Pecenka C, Jamison DT, Verguet S. Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis. PLoS One. 2015; 10(12):e0142691. PMID: 26650078.
    Citations: 14     Fields:    Translation:HumansCells
  111. Gelband H, Sankaranarayanan R, Gauvreau CL, Horton S, Anderson BO, Bray F, Cleary J, Dare AJ, Denny L, Gospodarowicz MK, Gupta S, Howard SC, Jaffray DA, Knaul F, Levin C, Rabeneck L, Rajaraman P, Sullivan T, Trimble EL, Jha P. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016 May 21; 387(10033):2133-2144. PMID: 26578033.
    Citations: 67     Fields:    Translation:Humans
  112. Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2015; 387(10028):1672-1685.
  113. Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Int J Obstet Anesth. 2016 Feb; 25:75-8. PMID: 26597405.
    Citations: 48     Fields:    Translation:Humans
  114. Uribe-Leitz T, Esquivel MM, Molina G, Lipsitz SR, Verguet S, Rose J, Bickler SW, Gawande AA, Haynes AB, Weiser TG. Projections for Achieving the Lancet Commission Recommended Surgical Rate of 5000 Operations per 100,000 Population by Region-Specific Surgical Rate Estimates. World J Surg. 2015 Sep; 39(9):2168-72. PMID: 26067635.
    Citations: 6     Fields:    Translation:Humans
  115. Driessen J, Olson ZD, Jamison DT, Verguet S. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis. Soc Sci Med. 2015 Aug; 139:115-22. PMID: 26189009.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  116. Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015; 8:27695. PMID: 26065636; PMCID: PMC4463495.
    Citations: 3     Fields:    Translation:Humans
  117. Hum RJ, Verguet S, Cheng YL, McGahan AM, Jha P. Are global and regional improvements in life expectancy and in child, adult and senior survival slowing? PLoS One. 2015; 10(5):e0124479. PMID: 25992949.
    Citations: 3     Fields:    Translation:Humans
  118. Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Ganbold L, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: Evidence and solutions for achieving health, welfare, and economic development. Surgery. 2015 Jul; 158(1):3-6. PMID: 25987187.
    Citations: 43     Fields:    Translation:Humans
  119. Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Am J Obstet Gynecol. 2015 Sep; 213(3):338-40. PMID: 25985722.
    Citations: 15     Fields:    
  120. Pecenka CJ, Johansson KA, Memirie ST, Jamison DT, Verguet S. Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in Ethiopia. BMJ Open. 2015 May 03; 5(4):e006402. PMID: 25941175.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  121. Verguet S, Olson ZD, Babigumira JB, Desalegn D, Johansson KA, Kruk ME, Levin CE, Nugent RA, Pecenka C, Shrime MG, Memirie ST, Watkins DA, Jamison DT. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis. Lancet Glob Health. 2015 May; 3(5):e288-96. PMID: 25889470.
    Citations: 40     Fields:    Translation:HumansPHPublic Health
  122. Verguet S, Alkire BC, Bickler SW, Lauer JA, Uribe-Leitz T, Molina G, Weiser TG, Yamey G, Shrime MG. Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study. Lancet Glob Health. 2015 Apr 27; 3 Suppl 2:S28-37. PMID: 25926318.
    Citations: 19     Fields:    Translation:Humans
  123. Stéphane Verguet, Blake C Alkire, Stephen W Bickler, Jeremy A Lauer, Tarsicio Uribe-Leitz, George Molina, Thomas G Weiser, Gavin Yamey, Mark G Shrime. Modeling the timing and cost of scaling up surgical services in low- and middle-income countries from 2012 to 2030. Lancet Global Health. 2015; 3:S28-S37.
  124. Uribe-Leitz T, Esquivel MM, Molina G, Lipsitz SR, Verguet S, Rose J, Bickler SW, Gawande AA, Haynes AB, Weiser TG. Projections to achieve minimum surgical rate threshold: an observational study. Lancet. 2015 Apr 27; 385 Suppl 2:S14. PMID: 26313060.
    Citations: 1     Fields:    
  125. Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015 Aug 08; 386(9993):569-624. PMID: 25924834.
    Citations: 684     Fields:    Translation:Humans
  126. Watkins DA, Olson ZD, Verguet S, Nugent RA, Jamison DT. Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis. Health Policy Plan. 2016 Feb; 31(1):75-82. PMID: 25841771; PMCID: PMC4724166.
    Citations: 24     Fields:    Translation:Humans
  127. Verguet S, Gauvreau CL, Mishra S, MacLennan M, Murphy SM, Brouwer ED, Nugent RA, Zhao K, Jha P, Jamison DT. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Glob Health. 2015 Apr; 3(4):e206-16. PMID: 25772692.
    Citations: 36     Fields:    Translation:HumansPHPublic Health
  128. Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2015 Jun 04; 33(24):2830-41. PMID: 25770785.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  129. Mock CN, Donkor P, Gawande A, Jamison DT, Kruk ME, Debas HT. Essential surgery: key messages from Disease Control Priorities, 3rd edition. Lancet. 2015 May 30; 385(9983):2209-19. PMID: 25662414; PMCID: PMC7004823.
    Citations: 102     Fields:    Translation:Humans
  130. Shrime MG, Verguet S, Johansson KA, Desalegn D, Jamison DT, Kruk ME. Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock, CN, eds. Disease Control Priorities. Task-sharing or public finance for the expansion of surgical access in rural Ethiopia: an extended cost-effectiveness analysis. 2015; 1.
  131. Levin CE, Sharma M, Olson Z, Verguet S, Shi J-F, Wang S-M, Qiao Y-L, Jamison DT, Kim J. Disease Control Priorities. An extended cost-eectiveness analysis of HPV vaccination to prevent cervical cancer in China. 2015; 3.
  132. Verguet S, Johri M, Morris SK, Gauvreau CL, Jha P, Jit M. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy. Vaccine. 2015 Mar 03; 33(10):1291-6. PMID: 25541214.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  133. Verguet S, Norheim OF, Olson ZD, Yamey G, Jamison DT. Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals. Lancet Glob Health. 2014 Dec; 2(12):e698-709. PMID: 25433625.
    Citations: 13     Fields:    Translation:Humans
  134. Norheim OF, Jha P, Admasu K, Godal T, Hum RJ, Kruk ME, Gómez-Dantés O, Mathers CD, Pan H, Sepúlveda J, Suraweera W, Verguet S, Woldemariam AT, Yamey G, Jamison DT, Peto R. Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health. Lancet. 2015 Jan 17; 385(9964):239-52. PMID: 25242039.
    Citations: 107     Fields:    Translation:Humans
  135. Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. BMJ Open. 2014 Jun 26; 4(6):e003987. PMID: 24969782.
    Citations: 5     Fields:    Translation:Humans
  136. Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson J. Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open. 2014 Mar 19; 4(3):e004308. PMID: 24647447.
    Citations: 1     Fields:    Translation:Humans
  137. Verguet S, Laxminarayan R, Jamison DT. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ. 2015 Mar; 24(3):318-32. PMID: 24497185.
    Citations: 52     Fields:    Translation:Humans
  138. Stéphane Verguet, Ole Frithjof Norheim, Zachary D Olson, Gavin Yamey, Dean T Jamison. Performance in reducing child, maternal, HIV and tuberculosis mortality rates across 109 low- and middle-income countries from 1990-2013. Lancet Global Health. 2014.
  139. Verguet S, Jassat W, Bertram MY, Tollman SM, Murray CJ, Jamison DT, Hofman KJ. Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa. J Epidemiol Community Health. 2013 Nov 01; 67(11):947-52. PMID: 23975755.
    Citations: 19     Fields:    Translation:HumansPHPublic Health
  140. Verguet S, Stalcup M, Walsh JA. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa? Sex Transm Infect. 2013 Dec; 89(8):628-34. PMID: 23912819.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  141. Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine. 2013 Oct 01; 31(42):4902-10. PMID: 23871824.
    Citations: 35     Fields:    Translation:HumansPHPublic Health
  142. Verguet S, Jamison DT. Improving life expectancy: how many years behind has the USA fallen? A cross-national comparison among high-income countries from 1958 to 2007. BMJ Open. 2013; 3(7). PMID: 23833143.
    Citations: 5     Fields:    
  143. Kern E, Verguet S, Yuhas K, Odhiambo FH, Kahn JG, Walson J. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study. Trop Med Int Health. 2013 Aug; 18(8):916-24. PMID: 23659539.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  144. Verguet S, Jassat W, Bertram MY, Tollman SM, Murray CJ, Jamison DT, Hofman KJ. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform. Glob Health Action. 2013 Mar 01; 6:1-9. PMID: 23458088.
    Citations: 7     Fields:    Translation:Humans
  145. Verguet S, Jamison DT. Estimates of performance in the rate of decline of under-five mortality for 113 low- and middle-income countries, 1970-2010. Health Policy Plan. 2014 Mar; 29(2):151-63. PMID: 23372036.
    Citations: 7     Fields:    Translation:Humans
  146. Verguet S. Efficient and equitable HIV prevention: A case study of male circumcision in South Africa. Cost Eff Resour Alloc. 2013 Jan 04; 11(1):1. PMID: 23289923.
    Citations: 12     
  147. Jamison DT, Jha P, Malhotra V, Verguet S. How much have global problems cost the world? - A scorecard from 1900 to 2050. The twentieth century transformation of human health: its magnitude and value. 2013.
  148. Jha P, Nugent R, Verguet S, Bloom D, Hum R. Global problems, smart solutions - Costs and benefits. Chronic disease prevention and control. 2013.
  149. Verguet S, Jamison DT. Performance in rate of decline of adult mortality in the OECD, 1970-2010. Health Policy. 2013 Feb; 109(2):137-42. PMID: 23195434.
    Citations: 5     Fields:    Translation:Humans
  150. Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. J Infect Dis. 2013 Jan 01; 207(1):72-9. PMID: 23100567.
    Citations: 13     Fields:    Translation:HumansCells
  151. Johri M, Sharma JK, Jit M, Verguet S. Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges. Vaccine. 2013 Feb 18; 31(9):1259-63. PMID: 23041086.
    Citations: 5     Fields:    Translation:Humans
  152. Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ. Measles control in Sub-Saharan Africa: South Africa as a case study. Vaccine. 2012 Feb 21; 30(9):1594-600. PMID: 22230581.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  153. Mothers and children: designing research toward inte-grated care for both. Health, Culture and Society. 2012; 3(1):160-171.
  154. Tasoglu S, Peters JJ, Park SC, Verguet S, Katz DF, Szeri AJ. The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle. Phys Fluids (1994). 2011 Sep; 23(9):93101-931019. PMID: 21998495.
    Citations: 11     
  155. Delva W, Verguet S, Hargrove J, Williams B, Sheneberger R, Stander T, Welte A. Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention. AIDS. 2011 Jul 17; 25(11):1435-7; author reply 1435. PMID: 21712655.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  156. Global health and the demands of the day. Health, Culture and Society. 2011; 1(1):30-44.
  157. Verguet S, Young Holt B, Szeri AJ. Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability. PLoS One. 2010 Nov 22; 5(11):e15501. PMID: 21124931.
    Citations: 6     Fields:    Translation:Humans
  158. Mechanics of liquid–liquid interfaces and mixing enhancement in microscale flows. Journal of Fluid Mechanics. 2010; 652:207-240.
  159. Verguet S, Walsh JA. Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA. Sex Transm Infect. 2010 Jun; 86(3):212-6. PMID: 20522634.
    Citations: 12     Fields:    Translation:Humans
  160. Verguet S, Duan C, Liau A, Berk V, Cate JHD, Majumdar A, Szeri AJ. Mechanics of liquid–liquid interfaces and mixing enhancement in microscale flows. Journal of Fluid Mechanics. 2010; 652:207–240.
  161. Epithelial coating mechanisms by semi-solid materials: application to microbicide gels. Biophysical Journal. 2010; 98(3):604a-604a.
  162. Szeri AJ, Park SC, Verguet S, Weiss A, Katz DF. A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding. Phys Fluids (1994). 2008 Aug; 20(8):83101. PMID: 19547722.
    Citations: 18     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Verguet's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.